Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 47

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Optineurin in Huntington's disease intranuclear inclusions

Schwab, Claudia, Yu, Sheng, McGeer, Edith G., McGeer, Patrick L. · 2012 · Neuroscience Letters

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neulet.2011.10.070

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 37

  1. Anborgh, 2005, Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin, J. Biol. Chem., 280, 34840, 10.1074/jbc.M504508200 · DOI · Paper page
  2. Apweiler, 2011, Ongoing and future developments at the Universal Protein Resource, Nucleic Acids Res., 39, D214, 10.1093/nar/gkq1020 · DOI · Paper page
  3. Becher, 1998, Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length, Neurobiol. Dis., 4, 387, 10.1006/nbdi.1998.0168 · DOI · Paper page
  4. Belzil, 2011, Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis, Neurobiol. Aging, 32, e513, 10.1016/j.neurobiolaging.2010.10.001 · DOI
  5. Bond, 2011, Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane, Mol. Biol. Cell, 22, 54, 10.1091/mbc.E10-06-0553 · DOI
  6. Chalasani, 2008, Focus on molecules: optineurin, Exp. Eye Res., 87, 1, 10.1016/j.exer.2007.10.021 · DOI
  7. Chalasani, 2009, Optineurin and its mutants: molecules associated with some forms of glaucoma, Ophthalmic Res., 42, 176, 10.1159/000232400 · DOI
  8. De Marco, 2006, Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus, J. Biol. Chem., 281, 16147, 10.1074/jbc.M601467200 · DOI · Paper page
  9. del Toro, 2009, Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus, Mol. Biol. Cell, 20, 1478, 10.1091/mbc.E08-07-0726 · DOI · Paper page
  10. DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 · DOI · Paper page
  11. Doi, 2010, The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases, Neurosci. Res., 66, 131, 10.1016/j.neures.2009.10.004 · DOI
  12. Gourfinkel-An, 1998, Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset, Neuroreport, 9, 1823, 10.1097/00001756-199806010-00028 · DOI
  13. Hattula, 2000, FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis, Curr. Biol., 10, 1603, 10.1016/S0960-9822(00)00864-2 · DOI · Paper page
  14. Hortobagyi, 2011, Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders, Acta Neuropathol., 121, 519, 10.1007/s00401-011-0813-3 · DOI
  15. Iida, 2011, Optineurin mutations in Japanese amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry
  16. Ito, 2011, Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease, Acta Neuropathol., 121, 555, 10.1007/s00401-011-0809-z · DOI
  17. Lagier-Tourenne, 2010, TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration, Hum. Mol. Genet., 19, R46, 10.1093/hmg/ddq137 · DOI · Paper page
  18. Li, 1998, Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains, Mol. Cell. Biol., 18, 1601, 10.1128/MCB.18.3.1601 · DOI · Paper page
  19. Maat-Schieman, 2007, Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington's disease, Brain Pathol., 17, 31, 10.1111/j.1750-3639.2006.00040.x · DOI
  20. Maat-Schieman, 1999, Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain, J. Neuropathol. Exp. Neurol., 58, 129, 10.1097/00005072-199902000-00003 · DOI
  21. Millecamps, 2011, Screening of OPTN in French familial amyotrophic lateral sclerosis, Neurobiol. Aging, 32, 557, 10.1016/j.neurobiolaging.2010.11.005 · DOI
  22. Moreland, 2000, Identification of a transcription factor IIIA-interacting protein, Nucleic Acids Res., 28, 1986, 10.1093/nar/28.9.1986 · DOI
  23. Nagabhushana, 2010, Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant, BMC Cell Biol., 11, 4, 10.1186/1471-2121-11-4 · DOI
  24. Osawa, 2011, Optineurin in neurodegenerative diseases, Neuropathology, 10.1111/j.1440-1789.2011.01199.x · DOI · Paper page
  25. Park, 2010, Impairment of protein trafficking upon overexpression and mutation of optineurin, PLoS One, 5, e11547, 10.1371/journal.pone.0011547 · DOI
  26. Park, 2006, Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types, Am. J. Pathol., 169, 1976, 10.2353/ajpath.2006.060400 · DOI · Paper page
  27. Rezaie, 2002, Adult-onset primary open-angle glaucoma caused by mutations in optineurin, Science, 295, 1077, 10.1126/science.1066901 · DOI · Paper page
  28. Rollinson, 2010, Analysis of optineurin in frontotemporal lobar degeneration, Neurobiol. Aging
  29. Rosas, 2008, Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity, Brain, 131, 1057, 10.1093/brain/awn025 · DOI · Paper page
  30. Sahlender, 2005, Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis, J. Cell Biol., 169, 285, 10.1083/jcb.200501162 · DOI · Paper page
  31. Schnell, 1999, Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue, J. Histochem. Cytochem., 47, 719, 10.1177/002215549904700601 · DOI · Paper page
  32. Schwamborn, 2000, Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-kappa B-independent pathway, J. Biol. Chem., 275, 22780, 10.1074/jbc.M001500200 · DOI
  33. Sudhakar, 2009, NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB, PLoS One, 4, e5114, 10.1371/journal.pone.0005114 · DOI
  34. Sugihara, 2011, Screening for OPTN mutations in amyotrophic lateral sclerosis in a mainly Caucasian population, Neurobiol. Aging, 10.1016/j.neurobiolaging.2011.03.024 · DOI
  35. Swarup, 2010, Optineurin, a multifunctional protein involved in glaucoma, amyotrophic lateral sclerosis and antiviral signalling, J. Biosci., 35, 501, 10.1007/s12038-010-0056-9 · DOI
  36. Vonsattel, 2008, Huntington disease models and human neuropathology: similarities and differences, Acta Neuropathol., 115, 55, 10.1007/s00401-007-0306-6 · DOI · Paper page
  37. Ying, 2010, Posttranslational modifications, localization, and protein interactions of optineurin, the product of a glaucoma gene, PLoS One, 5, e9168, 10.1371/journal.pone.0009168 · DOI

Cited by

See all 47

Metadata

Authors
Schwab, C., Yu, S., McGeer, E. G., & McGeer, P. L.
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2012-01
Volume
506
Issue
1
Pages
149-154
ISSN
0304-3940
Cited by
47
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
the Pacific Alzheimer Research Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.